Skip to main content
Clinical Orthopaedics and Related Research logoLink to Clinical Orthopaedics and Related Research
. 2017 Mar 6;475(6):1752. doi: 10.1007/s11999-017-5299-4

Erratum to: Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity

Krista A Goulding 1,, Adam Schwartz 2, Steven J Hattrup 2, R Lor Randall 3, Donald Lee 4, Damian M Rispoli 5, Daniel M Lerman 6, Christopher Beauchamp 2
PMCID: PMC5406350  PMID: 28265883

Erratum to: Clin Orthop Relat Res DOI: 10.1007/s11999-017-5258-0

A financial disclosure statement was improperly reported in the published study, “Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity.”

The study should have included the following statement: “The institution of one of the authors (DL) has received, during the study period, funding from NCATS/NI1H (UL1 TR000445) for the utilization of the REDCap (Research Electronic Data Capture) database.”

We apologize for the error.

Footnotes

The online version of the original article can be found under doi:10.1007/s11999-017-5258-0.

Contributor Information

Krista A. Goulding, Email: krista.goulding@mcgill.ca.

Adam Schwartz, Email: schwartz.adam@mayo.edu.


Articles from Clinical Orthopaedics and Related Research are provided here courtesy of The Association of Bone and Joint Surgeons

RESOURCES